Universal-Beteiligungs- und Servicegesellschaft’s Ultragenyx Pharmaceutical RARE Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$210K	Sell	6,301 -9,177	-59%	-$228K	﹤0.01%	2019
2026 Q1	$324K	Buy	15,478 +1,384	+10%	+$31.2K	﹤0.01%	1853
2025 Q4	$323K	Sell	14,094 -77,300	-85%	-$2.54M	﹤0.01%	1835
2025 Q3	$2.75M	Buy	91,394 +1,168	+1%	+$35K	﹤0.01%	1144
2025 Q2	$3.28M	Sell	90,226 -44,027	-33%	-$1.59M	0.01%	993
2025 Q1	$4.86M	Buy	134,253 +3,400	+3%	+$141K	0.01%	809
2024 Q4	$5.5M	Buy	+130,853	New	+$6.49M	0.01%	682

Other funds holding RARE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

EHI

Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's RARE Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Ultragenyx Pharmaceutical (RARE) stake by 59% in Q2 2026, selling an estimated $228K and leaving 6,301 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #2019.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in RARE in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.5M in Q4 2024. 157 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 6,301 shares of Ultragenyx Pharmaceutical worth $210K as of Q2 2026.
Universal-Beteiligungs- und Servicegesellschaft sold 9,177 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $228K.
Ultragenyx Pharmaceutical made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #2019 holding.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Ultragenyx Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
Universal-Beteiligungs- und Servicegesellschaft's Ultragenyx Pharmaceutical position peaked at $5.5M in Q4 2024.
157 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.